Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV‑3 human ovarian carcinoma cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncology Report

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2012.2214PMID 23292493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.

  2012cited by this paper
• Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models

  2011cited by this paper
• Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept.

  2011cited by this paper
• Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma.

  2011cited by this paper
• Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.

  2011cited by this paper
• Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification

  2011cited by this paper
• Matrix metalloproteinases in tumorigenesis: an evolving paradigm

  2011cited by this paper
• Matrix metalloproteinases: protective roles in cancer

  2011cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Epithelial-mesenchymal transition in ovarian cancer.

  2010influential reference
• Expression of matrix metalloproteinase‐1, ‐7, ‐9, ‐13, Ki‐67, and HER‐2 in epithelial‐myoepithelial salivary gland cancer

  2009cited by this paper
• Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.

  2009cited by this paper
• Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis.

  2009cited by this paper
• Overexpression of ErbB2 induces invasion of MCF10A human breast epithelial cells via MMP-9.

  2009influential reference
• Cancer Statistics, 2009

  2009cited by this paper
• [Influence of human epidermal growth factor receptor-2 siRNA on chemosensitivity to cisplatin of human ovarian carcinoma cells: an in vitro experiment].

  2008cited by this paper
• Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

  2008cited by this paper
• Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer.

  2006cited by this paper
• Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium.

  2006cited by this paper
• Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.

  2005cited by this paper
• c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation.

  2005cited by this paper
• ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors

  2005cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells

  2005cited by this paper
• RNA interference and its role in the regulation of eucaryotic gene expression.

  2003cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002influential reference
• Untangling the ErbB signalling network

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.

  2000cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.

  1997influential reference
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Prognostic significance of HER‐2/neu expression in advanced epithelial ovarian cancer: A multivariate analysis

  1993cited by this paper

• Ethyl Pyruvate as a Potential Therapeutic Agent for Endometriosis: A Perspective

  2025cites this paper
• NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models

  2024cites this paper
• Expression and clinical significance of lncRNA BC041954 in ovarian cancer.

  2022cites this paper
• Pharmacological Effects of Natural Components Against Ovarian Cancer and Mechanisms.

  2021cites this paper
• Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9

  2017cites this paper
• Suppression of human epidermal growth factor receptor 2 via interference increases the chemosensitivity of ovarian carcinoma

  2016cites this paper
• Preparaty siRNA w terapii genowej raka jajnika siRNA preparations in gene therapy of ovarian cancer

  2015cites this paper
• A mechanistic study on the anti-cancer activity of ethyl caffeate in human ovarian cancer SKOV-3 cells.

  2014cites this paper
• Characterization of Iron Response in Gynecological Cell Lines

  2014cites this paper
• The in vitro antitumor activity of Siegesbeckia glabrescens against ovarian cancer through suppression of receptor tyrosine kinase expression and the signaling pathways.

  2013cites this paper
• MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines.

  2013cites this paper